Alexander J. Szalai

The antimicrobial activity of C-reactive protein.

Experimental allergic encephalomyelitis is inhibited in transgenic mice expressing human C-reactive protein.

Varied biologic functions of C-reactive protein: lessons learned from transgenic mice.

Both family 1 and family 2 PspA proteins can inhibit complement deposition and confer virulence to a capsular serotype 3 strain of Streptococcus pneumoniae.

The biological functions of C-reactive protein.

Delayed lupus onset in (NZB x NZW)F1 mice expressing a human C-reactive protein transgene.

Fc gamma Rs modulate cytotoxicity of anti-Fas antibodies: implications for agonistic antibody-based therapeutics.

Increased thrombosis after arterial injury in human C-reactive protein-transgenic mice.

Effects of PspA and antibodies to PspA on activation and deposition of complement on the pneumococcal surface.

C-reactive protein accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice.

Evidence for anti-inflammatory activity of statins and PPARalpha activators in human C-reactive protein transgenic mice in vivo and in cultured human hepatocytes in vitro.

Fc receptors and the common gamma-chain in experimental autoimmune encephalomyelitis.

Murine complement C4 is not required for experimental autoimmune encephalomyelitis.

Effect of low dose atorvastatin versus diet-induced cholesterol lowering on atherosclerotic lesion progression and inflammation in apolipoprotein E*3-Leiden transgenic mice.

C-reactive protein (CRP) and autoimmune disease: facts and conjectures.

The virulence function of Streptococcus pneumoniae surface protein A involves inhibition of complement activation and impairment of complement receptor-mediated protection.

Estrogen treatment abrogates neointima formation in human C-reactive protein transgenic mice.

C3a expressed in the central nervous system protects against LPS-induced shock.

Complement as a biomarker in multiple sclerosis.

Genetic deficiency of C3 as well as CNS-targeted expression of the complement inhibitor sCrry ameliorates experimental autoimmune uveoretinitis.

Requirement of the Fc receptor common gamma-chain for gamma delta T cell-mediated promotion of murine experimental autoimmune encephalomyelitis.

Complement in BuB/BnJ mice revisited: serum C3 levels and complement opsonic activity are not elevated.

Complement and demyelinating disease: no MAC needed?

Experimental autoimmune uveitis in the C57BL/6 mouse.

Induction of leptin resistance through direct interaction of C-reactive protein with leptin.

Complement in experimental autoimmune encephalomyelitis revisited: C3 is required for development of maximal disease.

C-reactive protein gene polymorphisms, C-reactive protein blood levels, and cardiovascular disease risk.

PspA and PspC minimize immune adherence and transfer of pneumococci from erythrocytes to macrophages through their effects on complement activation.

Exaggerated neointima formation in human C-reactive protein transgenic mice is IgG Fc receptor type I (Fc gamma RI)-dependent.

Neointimal formation is reduced after arterial injury in human crp transgenic mice.

Impaired endothelial function in C-reactive protein overexpressing mice.

Immune opsonins modulate BLyS/BAFF release in a receptor-specific fashion.

Antibody to the type 3 capsule facilitates immune adherence of pneumococci to erythrocytes and augments their transfer to macrophages.

The role of C-reactive protein polymorphisms in inflammation and cardiovascular risk.

C-reactive protein promotes cardiac fibrosis and inflammation in angiotensin II-induced hypertensive cardiac disease.

C-reactive protein-mediated vascular injury requires complement.

Complement receptor 1 expression on mouse erythrocytes mediates clearance of Streptococcus pneumoniae by immune adherence.

Inhibition of Experimental Autoimmune Encephalomyelitis in Human C-Reactive Protein Transgenic Mice Is FcγRIIB Dependent.

C-reactive protein promotes acute renal inflammation and fibrosis in unilateral ureteral obstructive nephropathy in mice.

Collagen-induced arthritis is exacerbated in C-reactive protein-deficient mice.

An about-face for C-reactive protein?

Biomarkers of inflammation and hemostasis associated with left ventricular mass: The Multiethnic Study of Atherosclerosis (MESA).

Kidney injury accelerates cystogenesis via pathways modulated by heme oxygenase and complement.

Associations of C-Reactive Protein to Indices of Vascular Health and the Influence of Serum 25(OH)D Status in Healthy Adults.

Pneumococcal surface protein A inhibits complement deposition on the pneumococcal surface by competing with the binding of C-reactive protein to cell-surface phosphocholine.

C-reactive protein exacerbates renal ischemia-reperfusion injury.

A Selective Inhibitor of Human C-reactive Protein Translation Is Efficacious In Vitro and in C-reactive Protein Transgenic Mice and Humans.

Multiple lupus-associated ITGAM variants alter Mac-1 functions on neutrophils.

C-reactive protein promotes acute kidney injury by impairing G1/S-dependent tubular epithelium cell regeneration.

Inhibiting C-reactive protein for the treatment of cardiovascular disease: promising evidence from rodent models.

Associations between Abnormal Rod-Mediated Dark Adaptation and Health and Functioning in Older Adults with Normal Macular Health.

Estrogen effects on vascular inflammation are age dependent: role of estrogen receptors.